The Oncology Shot with Timothee Olivier: Who It's For and Who Sponsors It

Covers: Critical analysis of oncology clinical trials, statistical methods, cancer drug regulatory approvals, and industry financial influence.
For: Oncologists, medical researchers, and clinical trial specialists evaluating cancer therapies.
Best for: Clinical oncologists and cancer researchers seeking methodological critique of new oncology studies.
Skip if: Patients looking for personal medical advice or cancer support resources.

Start with

Currency of Influence in Oncology: Explores how industry payments influence physician prescribing decisions for expensive cancer therapies.
My Fribourg talk, in French! Statistics in Oncology in Practice: Provides practical guidance on interpreting Kaplan-Meier plots and informative censoring in cancer studies.
“Chemo‑free” is not always better: the FDA withdrawal of adagrasib in colorectal cancer: Analyzes regulatory decisions, marketing narratives, and evidence limitations surrounding accelerated targeted therapy approvals.

Summarised by AI from 12 recent issues. Audience size is not included. Prices are not included. Report a mistake.